Population pharmacokinetic investigation of digoxin in Japanese neonates

Objective:  To establish the role of patient characteristics in estimating doses of digoxin for neonates using routine therapeutic drug monitoring data.

[1]  Lewis B. Sheiner,et al.  Some suggestions for measuring predictive performance , 1981, Journal of Pharmacokinetics and Biopharmaceutics.

[2]  Lewis B. Sheiner,et al.  Estimation of population characteristics of pharmacokinetic parameters from routine clinical data , 1977, Journal of Pharmacokinetics and Biopharmaceutics.

[3]  H. Halkin,et al.  Steady state serum concentrations and renal clearance of digoxin in neonates, infants and children , 1978, European Journal of Clinical Pharmacology.

[4]  K. Andersson,et al.  Absorption of digoxin in infants , 1975, European Journal of Clinical Pharmacology.

[5]  G. Wettrell.  Distribution and elimination of digoxin in infants , 2004, European Journal of Clinical Pharmacology.

[6]  S. Higuchi,et al.  Population‐Based Investigation of Relative Clearance of Digoxin in Japanese Patients by Multiple Trough Screen Analysis: An Update , 1997, Journal of clinical pharmacology.

[7]  E. Yukawa,et al.  Digoxin Population Pharmacokinetics from Routine Clinical Data: Role of Patient Characteristics for Estimating Dosing Regimens , 1992, The Journal of pharmacy and pharmacology.

[8]  L B Sheiner,et al.  Premarketing observational studies of population pharmacokinetics of new drugs , 1985, Clinical pharmacology and therapeutics.

[9]  M. Whitfield,et al.  Seven different digoxin immunoassay kits compared with respect to interference by a digoxin-like immunoreactive substance in serum from premature and full-term infants. , 1983, Clinical chemistry.

[10]  S. Graves,et al.  Endogenous substance in newborn infants causing false positive digoxin measurements. , 1983, The Journal of pediatrics.

[11]  G. Wettrell,et al.  Digoxin Dosage Schedules for Neonates and Infants Based on Pharmacokinetic Considerations , 1978, Clinical pharmacokinetics.

[12]  S. Garattini,et al.  Basic and Therapeutic Aspects of Perinatal Pharmacology , 1976 .

[13]  J. Wagner.  Appraisal of digoxin bioavailability and pharmacokinetics in relation to cardiac therapy. , 1974, American heart journal.

[14]  C. Lowe.  Pediatric pharmacology. , 1968, The Journal of clinical pharmacology and the journal of new drugs.